Drug Type Small molecule drug |
Synonyms (±)-3-ethyl-5-phenylhydantoin, 1-ethyl-2,5-dioxo-4-phenylimidazolidine, 3-ethyl-5-phenyl-2,4-imidazolidinedione + [9] |
Target |
Action blockers |
Mechanism SCNA blockers(Sodium voltage-gated channel alpha subunits blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
Regulation- |
Molecular FormulaC11H12N2O2 |
InChIKeySZQIFWWUIBRPBZ-UHFFFAOYSA-N |
CAS Registry86-35-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Epilepsy, Tonic-Clonic | Japan | 03 Feb 1960 | |
Epilepsy | United States | 22 Apr 1957 | |
Seizures | United States | 22 Apr 1957 |